Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global autoimmune disease diagnosis market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028. The increasing incidences of autoimmune diseases, rising sales of insurance policies, and the growing use of EMRs represent some of the key factors driving the market.
An autoimmune disease is a group of disorders wherein the immune system attacks the cells, tissues, and organs of the body. It can be caused by different medical conditions, such as systemic lupus erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes. It is associated with fatigue, joint pain and stiffness, skin rashes, fever, and digestive problems. It can also cause damage to organs and tissues, which leads to more severe symptoms like difficulty breathing, organ failure, or even death. It can be diagnosed via a combination of various approaches, such as taking a detailed medical history, performing a physical examination, blood tests to detect specific antibodies, imaging tests to look for damage or inflammation, and a biopsy to examine the affected tissue under a microscope.
Autoimmune Disease Diagnosis Market Trends:
The surging incidences of autoimmune diseases among individuals and the increasing aging population that are susceptible to develop such medical conditions represent one of the major factors driving the demand for autoimmune disease diagnosis around the world. Moreover, the rising awareness about autoimmune disease, its symptoms, diagnosis, and the easy availability of the treatment options is favoring the growth of the market. In addition, the growing implementation of health insurance policies that offer financial assistance for autoimmune disease diagnosis or treatment and reduce overall medical expenses is influencing the market positively. Apart from this, governing authorities of several countries are financing research and development (R&D) projects to study autoimmune diseases and develop new treatments. They are also investing in programs that aim to develop improved diagnostic methods for these medical disorders. Besides this, they are undertaking initiatives to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is strengthening the growth of the market. Furthermore, there is an increase in the use of electronic medical records (EMRs) to improve the accuracy and speed of autoimmune disease diagnosis as healthcare professionals have access to more comprehensive patient information. This, along with the rising adoption of telemedicine is catalyzing the demand for remote autoimmune disease diagnosis and monitoring technologies. Besides this, the growing demand for non invasive diagnosis, which is less painful as compared to traditional diagnostic procedures, is creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global autoimmune disease diagnosis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, disease type, test type and end-user.
Product Type Insights:
Consumables and Assay Kits
Instruments
The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the product type. This includes consumables and assay kits, and instruments. According to the report, consumables and assay kits represented the largest segment.
Disease Type Insights:
Systemic Autoimmune Disease
Rheumatoid Arthritis
Psoriasis
Systemic Lupus Erythematosus (SLE)
Multiple Sclerosis
Others
Localized Autoimmune Disease
Inflammatory Bowel Disease
Type 1 Diabetes
Thyroid
Others
A detailed breakup and analysis of the autoimmune disease diagnosis market based on the disease type has also been provided in the report. This includes systemic autoimmune disease (rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE), multiple sclerosis, and others) and localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others). According to the report, localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others) accounted for the largest market share.
Test Type Insights:
Routine Laboratory Tests
Inflammatory Markers
Autoantibodies and Immunologic Tests
Others
The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the test type. This includes routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and others. According to the report, routine laboratory tests represented the largest segment.
End-User Insights:
Clinical Laboratories
Hospitals
Others
A detailed breakup and analysis of the autoimmune disease diagnosis market based on the end-user has also been provided in the report. This includes clinical laboratories, hospitals, and others. According to the report, clinical laboratories accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for autoimmune disease diagnosis. Some of the factors driving the North America autoimmune disease diagnosis market included the easy availability of treatments, technological advancements, extensive research and development (R&D) projects, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global autoimmune disease diagnosis market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMйrieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech plc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What is the size of the global autoimmune disease diagnosis market?
2. What has been the impact of COVID-19 on the global autoimmune disease diagnosis market?
3. What is the expected growth rate of the global autoimmune disease diagnosis market?
4. What are the key factors driving the global autoimmune disease diagnosis market?
5. What is the breakup of the global autoimmune disease diagnosis market based on the product type?
6. What is the breakup of the global autoimmune disease diagnosis market based on the disease type?
7. What is the breakup of the global autoimmune disease diagnosis market based on the test type?
8. What are the key regions in the global autoimmune disease diagnosis market?
9. Who are the key players/companies in the global autoimmune disease diagnosis market?
The global autoimmune disease diagnosis market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028. The increasing incidences of autoimmune diseases, rising sales of insurance policies, and the growing use of EMRs represent some of the key factors driving the market.
An autoimmune disease is a group of disorders wherein the immune system attacks the cells, tissues, and organs of the body. It can be caused by different medical conditions, such as systemic lupus erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes. It is associated with fatigue, joint pain and stiffness, skin rashes, fever, and digestive problems. It can also cause damage to organs and tissues, which leads to more severe symptoms like difficulty breathing, organ failure, or even death. It can be diagnosed via a combination of various approaches, such as taking a detailed medical history, performing a physical examination, blood tests to detect specific antibodies, imaging tests to look for damage or inflammation, and a biopsy to examine the affected tissue under a microscope.
Autoimmune Disease Diagnosis Market Trends:
The surging incidences of autoimmune diseases among individuals and the increasing aging population that are susceptible to develop such medical conditions represent one of the major factors driving the demand for autoimmune disease diagnosis around the world. Moreover, the rising awareness about autoimmune disease, its symptoms, diagnosis, and the easy availability of the treatment options is favoring the growth of the market. In addition, the growing implementation of health insurance policies that offer financial assistance for autoimmune disease diagnosis or treatment and reduce overall medical expenses is influencing the market positively. Apart from this, governing authorities of several countries are financing research and development (R&D) projects to study autoimmune diseases and develop new treatments. They are also investing in programs that aim to develop improved diagnostic methods for these medical disorders. Besides this, they are undertaking initiatives to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is strengthening the growth of the market. Furthermore, there is an increase in the use of electronic medical records (EMRs) to improve the accuracy and speed of autoimmune disease diagnosis as healthcare professionals have access to more comprehensive patient information. This, along with the rising adoption of telemedicine is catalyzing the demand for remote autoimmune disease diagnosis and monitoring technologies. Besides this, the growing demand for non invasive diagnosis, which is less painful as compared to traditional diagnostic procedures, is creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global autoimmune disease diagnosis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, disease type, test type and end-user.
Product Type Insights:
Consumables and Assay Kits
Instruments
The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the product type. This includes consumables and assay kits, and instruments. According to the report, consumables and assay kits represented the largest segment.
Disease Type Insights:
Systemic Autoimmune Disease
Rheumatoid Arthritis
Psoriasis
Systemic Lupus Erythematosus (SLE)
Multiple Sclerosis
Others
Localized Autoimmune Disease
Inflammatory Bowel Disease
Type 1 Diabetes
Thyroid
Others
A detailed breakup and analysis of the autoimmune disease diagnosis market based on the disease type has also been provided in the report. This includes systemic autoimmune disease (rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE), multiple sclerosis, and others) and localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others). According to the report, localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others) accounted for the largest market share.
Test Type Insights:
Routine Laboratory Tests
Inflammatory Markers
Autoantibodies and Immunologic Tests
Others
The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the test type. This includes routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and others. According to the report, routine laboratory tests represented the largest segment.
End-User Insights:
Clinical Laboratories
Hospitals
Others
A detailed breakup and analysis of the autoimmune disease diagnosis market based on the end-user has also been provided in the report. This includes clinical laboratories, hospitals, and others. According to the report, clinical laboratories accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for autoimmune disease diagnosis. Some of the factors driving the North America autoimmune disease diagnosis market included the easy availability of treatments, technological advancements, extensive research and development (R&D) projects, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global autoimmune disease diagnosis market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMйrieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech plc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What is the size of the global autoimmune disease diagnosis market?
2. What has been the impact of COVID-19 on the global autoimmune disease diagnosis market?
3. What is the expected growth rate of the global autoimmune disease diagnosis market?
4. What are the key factors driving the global autoimmune disease diagnosis market?
5. What is the breakup of the global autoimmune disease diagnosis market based on the product type?
6. What is the breakup of the global autoimmune disease diagnosis market based on the disease type?
7. What is the breakup of the global autoimmune disease diagnosis market based on the test type?
8. What are the key regions in the global autoimmune disease diagnosis market?
9. Who are the key players/companies in the global autoimmune disease diagnosis market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Consumables and Assay Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DISEASE TYPE
7.1 Systemic Autoimmune Disease
7.1.1 Market Trends
7.1.2 Market Breakup by Type
7.1.2.1 Rheumatoid Arthritis
7.1.2.2 Psoriasis
7.1.2.3 Systemic Lupus Erythematosus (SLE)
7.1.2.4 Multiple Sclerosis
7.1.2.5 Others
7.1.3 Market Forecast
7.2 Localized Autoimmune Disease
7.2.1 Market Trends
7.2.2 Market Breakup by Type
7.2.2.1 Inflammatory Bowel Disease
7.2.2.2 Type 1 Diabetes
7.2.2.3 Thyroid
7.2.2.4 Others
7.2.3 Market Forecast
8 MARKET BREAKUP BY TEST TYPE
8.1 Routine Laboratory Tests
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Inflammatory Markers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Autoantibodies and Immunologic Tests
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END-USER
9.1 Clinical Laboratories
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AESKU.GROUP
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Danaher Corp.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 bioMйrieux SA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Bio-Rad Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 PerkinElmer Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Hemagen Diagnostics, Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Inova Diagnostics, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Myriad Genetics, Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Quest Diagnostics Incorporated
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Siemens Healthineers AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 SQI Diagnostics
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.13 Thermo Fisher Scientific Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
14.3.14 Trinity Biotech plc
14.3.14.1 Company Overview
14.3.14.2 Product Portfolio
14.3.14.3 Financials
14.3.14.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Consumables and Assay Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DISEASE TYPE
7.1 Systemic Autoimmune Disease
7.1.1 Market Trends
7.1.2 Market Breakup by Type
7.1.2.1 Rheumatoid Arthritis
7.1.2.2 Psoriasis
7.1.2.3 Systemic Lupus Erythematosus (SLE)
7.1.2.4 Multiple Sclerosis
7.1.2.5 Others
7.1.3 Market Forecast
7.2 Localized Autoimmune Disease
7.2.1 Market Trends
7.2.2 Market Breakup by Type
7.2.2.1 Inflammatory Bowel Disease
7.2.2.2 Type 1 Diabetes
7.2.2.3 Thyroid
7.2.2.4 Others
7.2.3 Market Forecast
8 MARKET BREAKUP BY TEST TYPE
8.1 Routine Laboratory Tests
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Inflammatory Markers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Autoantibodies and Immunologic Tests
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY END-USER
9.1 Clinical Laboratories
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AESKU.GROUP
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Danaher Corp.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 bioMйrieux SA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Bio-Rad Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 PerkinElmer Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Hemagen Diagnostics, Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Inova Diagnostics, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Myriad Genetics, Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Quest Diagnostics Incorporated
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Siemens Healthineers AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 SQI Diagnostics
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.13 Thermo Fisher Scientific Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
14.3.14 Trinity Biotech plc
14.3.14.1 Company Overview
14.3.14.2 Product Portfolio
14.3.14.3 Financials
14.3.14.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Autoimmune Disease Diagnosis Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 4: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 5: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by End-User (in Million US$), 2023-2028
Table 6: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Autoimmune Disease Diagnosis Market Structure
Table 8: Global: Autoimmune Disease Diagnosis Market: Key Players
Table 1: Global: Autoimmune Disease Diagnosis Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 4: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 5: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by End-User (in Million US$), 2023-2028
Table 6: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Autoimmune Disease Diagnosis Market Structure
Table 8: Global: Autoimmune Disease Diagnosis Market: Key Players
LIST OF FIGURES
Figure 1: Global: Autoimmune Disease Diagnosis Market: Major Drivers and Challenges
Figure 2: Global: Autoimmune Disease Diagnosis Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Autoimmune Disease Diagnosis Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Autoimmune Disease Diagnosis Market: Breakup by Disease Type (in %), 2022
Figure 5: Global: Autoimmune Disease Diagnosis Market: Breakup by Test Type (in %), 2022
Figure 6: Global: Autoimmune Disease Diagnosis Market: Breakup by End-User (in %), 2022
Figure 7: Global: Autoimmune Disease Diagnosis Market: Breakup by Region (in %), 2022
Figure 8: Global: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Autoimmune Disease Diagnosis (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Autoimmune Disease Diagnosis (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
Figure 15: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
Figure 18: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Autoimmune Disease Diagnosis (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Autoimmune Disease Diagnosis (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Autoimmune Disease Diagnosis (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Autoimmune Disease Diagnosis (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Autoimmune Disease Diagnosis (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Autoimmune Disease Diagnosis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: North America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: United States: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: United States: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Canada: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Canada: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia Pacific: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Asia Pacific: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: China: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: China: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Japan: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Japan: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: India: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: India: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: South Korea: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: South Korea: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Australia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Australia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Indonesia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Indonesia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Europe: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Europe: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Germany: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Germany: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: France: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: France: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: United Kingdom: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: United Kingdom: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Italy: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Italy: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Spain: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Spain: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Russia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Russia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Latin America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Latin America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Brazil: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Brazil: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Mexico: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Mexico: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Middle East and Africa: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Middle East and Africa: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Autoimmune Disease Diagnosis Industry: SWOT Analysis
Figure 82: Global: Autoimmune Disease Diagnosis Industry: Value Chain Analysis
Figure 83: Global: Autoimmune Disease Diagnosis Industry: Porter’s Five Forces Analysis
Figure 1: Global: Autoimmune Disease Diagnosis Market: Major Drivers and Challenges
Figure 2: Global: Autoimmune Disease Diagnosis Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Autoimmune Disease Diagnosis Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Autoimmune Disease Diagnosis Market: Breakup by Disease Type (in %), 2022
Figure 5: Global: Autoimmune Disease Diagnosis Market: Breakup by Test Type (in %), 2022
Figure 6: Global: Autoimmune Disease Diagnosis Market: Breakup by End-User (in %), 2022
Figure 7: Global: Autoimmune Disease Diagnosis Market: Breakup by Region (in %), 2022
Figure 8: Global: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Autoimmune Disease Diagnosis (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Autoimmune Disease Diagnosis (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
Figure 15: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
Figure 18: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Autoimmune Disease Diagnosis (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Autoimmune Disease Diagnosis (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Autoimmune Disease Diagnosis (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Autoimmune Disease Diagnosis (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Autoimmune Disease Diagnosis (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Autoimmune Disease Diagnosis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: North America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: United States: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: United States: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Canada: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Canada: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia Pacific: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Asia Pacific: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: China: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: China: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Japan: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Japan: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: India: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: India: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: South Korea: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: South Korea: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Australia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Australia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Indonesia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Indonesia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Europe: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Europe: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Germany: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Germany: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: France: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: France: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: United Kingdom: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: United Kingdom: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Italy: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Italy: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Spain: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Spain: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Russia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Russia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Latin America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Latin America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Brazil: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Brazil: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Mexico: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Mexico: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Middle East and Africa: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Middle East and Africa: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Autoimmune Disease Diagnosis Industry: SWOT Analysis
Figure 82: Global: Autoimmune Disease Diagnosis Industry: Value Chain Analysis
Figure 83: Global: Autoimmune Disease Diagnosis Industry: Porter’s Five Forces Analysis
